Form 4 for OPCH Option Care Health, Inc.
Accepted 2023-02-22 00:00:00 ET · period of report 2020-08-01 · accession 0001437749-23-004245 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-22 | 2020-08-01+ | OPCH | DENNESS RICHARD | Chief Commercial Off | M - OptEx | $0.00 | +33.0K | 71.9K | +85% | $0 |
| DM | 2023-02-22 | 2020-08-01+ | OPCH | DENNESS RICHARD | Chief Commercial Off | F - Tax | $17.36 | -13.4K | 65.2K | -17% | -$232.4K |
| DM | 2023-02-22 | 2020-08-01+ | OPCH | DENNESS RICHARD | Chief Commercial Off | M - OptEx | $0.00 | -33.0K | 4,735 | -87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-17 | M | A | 2,348 | $0.00 | 67,717 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-17 | F | D | 760 | $29.38 | 66,957 | D | — | — | |
| 3 | Common | Common Stock | 2020-08-01 | F | D | 1,352 | $11.78 | 50,725 | D | — | — | |
| 4 | Common | Common Stock | 2020-08-01 | M | A | 4,735 | $0.00 | 52,077 | D | — | — | (F1) Previous number of shares beneficially owned, 92,236, reported on the Form 4 filed on July 13, 2021, has been adjusted to 47,342 to reflect the 1-for-4 reverse stock split of the Issuer's Common Stock that occurred on February 3, 2020. |
| 5 | Common | Common Stock | 2022-03-09 | F | D | 3,288 | $26.16 | 65,369 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-01 | F | D | 1,281 | $20.72 | 68,657 | D | — | — | |
| 7 | Common | Common Stock | 2021-08-01 | M | A | 4,735 | $0.00 | 69,938 | D | — | — | |
| 8 | Common | Common Stock | 2020-08-06 | F | D | 6,709 | $12.16 | 65,203 | D | — | — | |
| 9 | Common | Common Stock | 2020-08-06 | M | A | 21,187 | $0.00 | 71,912 | D | — | — | |
| 10 | Derivative | Restricted Stock Unit | 2023-02-17 | M | D | 2,348 | $0.00 | 7,044 | D | — · — to — | 2,348 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock. (F6) All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversary of the grant date, February 27, 2022. |
| 11 | Derivative | Restricted Stock Unit | 2021-08-01 | M | D | 4,735 | $0.00 | 0 | D | — · — to — | 4,735 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock. (F4) Fully vested. |
| 12 | Derivative | Restricted Stock Unit | 2020-08-06 | M | D | 21,187 | $0.00 | 0 | D | — · — to — | 21,187 Common Stock | (F5) Number of RSUs vesting was adjusted from 84,746 RSUs to 21,187 RSUs to reflect the 1-for-4 reverse stock split of Issuer's Common Stock that occurred on February 3, 2020. (F2) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock. (F4) Fully vested. |
| 13 | Derivative | Restricted Stock Unit | 2020-08-01 | M | D | 4,735 | $0.00 | 4,735 | D | — · — to — | 4,735 Common Stock | (F3) Number of RSUs vesting was adjusted from 37,878 RSUs to 9,470 RSUs to reflect the 1-for-4 reverse stock split of Issuer's Common Stock that occurred on February 3, 2020. (F2) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock. (F4) Fully vested. |